Home » FDA Grants Marketing Clearance to Cepheid’s Next-Generation Test for MRSA Colonization
FDA Grants Marketing Clearance to Cepheid’s Next-Generation Test for MRSA Colonization
Sunnyvale, California-based Cepheid received clearance from the FDA for Xpert MRSA NxG methicillin-resistant Staphylococcus aureus (MRSA) infection control test.
Xpert MRSA NxG is a molecular test that delivers results in about an hour.
The test has been validated for use with both ESwab (Copan) and rayon swabs. — Cynthia Jessup
Upcoming Events
-
07May
-
14May
-
30May